Search

everythinglearnresearchcommunity

for

Search:↓

Hair transplants can effectively treat hair loss from CCCA in African American women if there's no inflammation.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Microsponges delivery system is a safe, versatile method for controlled drug release in various treatments.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Topical treatment is recommended for Folliculitis decalvans in pregnant women.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Tacrolimus solution is effective and well-tolerated for treating inflammatory scalp conditions.

A child with a rare scalp condition regrew hair after treatment.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The document explains various skin conditions and their treatments.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

The document says how to diagnose and treat hair loss from alopecia areata, but there's no cure and treatments vary.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

A 5-year-old boy with alopecia totalis had temporary hair regrowth with treatment but relapsed, highlighting the need for thorough investigation and holistic care.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Topical metformin may improve hair regrowth in CCCA when added to standard treatments.

Dithranol is more effective than Tacrolimus for hair regrowth in alopecia areata.

Topical metformin shows promise for dental and skin treatments, including periodontitis, hair regrowth, wound healing, and acne.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Cubosomes improve drug delivery for skin and eye diseases by enhancing adhesion, retention, and release.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.